Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group — Memphis, Tennessee

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group has participated in 5 clinical trials.

Therapeutic areas: Pancreatic Cancer, Leukemia, Lymphoma.

Sponsors: Theradex, Pharmatech Oncology, Amgen.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group?

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group conducted?

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group has 5 clinical trials on record. Their work covers Pancreatic Cancer, Leukemia, Lymphoma.

Is Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group accredited by Crixeo Health?

Yes — Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.